{"schema_version":"secwatch.filing_event.v1","accession":"0001710155-22-000017","form_type":"8-K","ticker":"EYE","cik":"0001710155","company_name":"National Vision Holdings, Inc.","filed_at":"2022-05-10T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.941174+00:00","generated_at":"2026-06-25T21:49:13.861170+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"National Vision Q1 revenue down 1.2% to $527.7M; cuts FY2022 outlook","bullets":["Net revenue $527.7M (-1.2% YoY); comparable store sales growth (4.9)%, adjusted (6.8)%.","Net income $30.1M (-30.6%); diluted EPS $0.34; adjusted diluted EPS $0.33 (-31.5% YoY).","Adjusted operating income $45.3M (-33%); updates FY2022 outlook citing Omicron, consumer weakness, exam capacity constraints.","Accelerating remote medicine rollout; first pricing change to America's Best signature offer in over 15 years.","Opened 17 new stores including two Eyeglass World locations during Q1."],"urls":{"canonical":"https://secwatch.observer/filing/0001710155-22-000017","json":"https://secwatch.observer/filing/0001710155-22-000017.json","markdown":"https://secwatch.observer/filing/0001710155-22-000017.md","text":"https://secwatch.observer/filing/0001710155-22-000017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1710155/000171015522000017/0001710155-22-000017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1710155/000171015522000017/eye-20220510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T21:49:13.861170+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}